Post-Brexit, the UK’s MHRA is looking to join Project Orbis, a global program to speed up patient access to innovative cancer treatments. This article looks at the implications of Project Orbis for commercialization in the UK and the key considerations for industry in considering the project as a pathway.
Press contacts
Contact us
Our experts are always happy to discuss your issue. Reach out, and we’ll connect you with a member of our team.